Gabapentin blocks and reverses antinociceptive morphine tolerance in the rat paw-pressure and tail-flick tests

Anesthesiology

Volumn 98, Issue 5, 2003, Pages 1288-1292

  Gilron, Ian ^a,d   Biederman, Jessica ^b   Jhamandas, Khem ^b   Hong, Murray ^c  

^a Clinical Pain Research   (Canada)

^b Department of Anesthesiology ^*  (Canada)

^c Department of Anesthesiology   (Canada)

^d QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN; MORPHINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; MALE; MORPHINE TOLERANCE; NEUROMODULATION; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; TAIL FLICK TEST;

ACETIC ACIDS; AMINES; ANALGESICS, OPIOID; ANIMALS; CYCLOHEXANECARBOXYLIC ACIDS; DISEASE MODELS, ANIMAL; DRUG TOLERANCE; EXCITATORY AMINO ACID ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; MALE; MORPHINE; NARCOTIC ANTAGONISTS; PAIN; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; TAIL;

EID: 0037408517     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200305000-00037     Document Type: Article

References (32)

1. Foley KM. Opioids: Neurol Clin 1993; 11:503-22
2. Vigano A, Fan D, Bruera E: Individualized use of methadone and opioid rotation in the comprehensive management of cancer pain associated with poor prognostic indicators. Pain 1996; 67:115-9
3. Sallerin-Caute B, Lazorthes Y, Deguine O, Frances B, Verdie JC, Charlet JP, Bastide R: Does intrathecal morphine in the treatment of cancer pain induce the development of tolerance? Neurosurgery 1998; 42:44-9
4. Guignard B, Bossard AE, Coste C, Sessler DI, Lebrault C, Alfonsi P, Fletcher D, Chauvin M: Acute opioid tolerance: Intraoperative remifentanil increases postoperative pain and morphine requirement. ANESTHESIOLOGY 2000; 93:409-17
5. Cortinez LI, Brandes V, Munoz HR, Guerrero ME, Mur M: No clinical evidence of acute opioid tolerance after remifentanil-based anaesthesia. Br J Anaesth 2001; 87:866-9
6. Mayer DJ, Mao J, Holt J, Price DD: Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. Proc Natl Acad Sci USA 1999; 96: 7731-6
7. Kest B, McLemore G, Kao B, Inturrisi CE: The competitive alpha-amino-3hydroxy-5-methylisoxazole-4-propionate receptor antagonist LY293558 attenuates and reverses analgesic tolerance to morphine but not to delta or kappa opioids. J Pharmacol Exp Ther 1997; 283:1249-55
8. Vanderah TW, Ossipov MH, Lai J, Malan TP Jr, Porreca F: Mechanisms of opioid-induced pain and antinociceptive tolerance: Descending facilitation and spinal dynorphin. Pain 2001; 92:5-9
9. Powell KJ, Ma W, Sutak M, Doods H, Quirion R, Jhamandas K: Blockade and reversal of spinal morphine tolerance by peptide and non-peptide calcitonin gene-related peptide receptor antagonists. Br J Pharmacol 2000; 131:875-84
10. Powell KJ, Hosokawa A, Bell A, Sutak M, Milne B, Quirion R, Jhamandas K: Comparative effects of cyclo-oxygenase and nitric oxide synthase inhibition on the development and reversal of spinal opioid tolerance. Br J Pharmacol 1999; 127:631-44
11. Stubhaug A, Breivik H, Eide PK, Kreunen M, Foss A: Mapping of punctuate hyperalgesia around a surgical incision demonstrates that ketamine is a powerful suppressor of central sensitization to pain following surgery. Acta Anaesthesiol Scand 1997; 41:1124-32
12. Gilron I, Max MB, Lee G, Booher SL, Sang CN, Chappell AS, Dionne RA: Effects of the 2-amino-3-hydroxy-5-methyl-4-isoxazole-proprionic acid/kainate antagonist LY293558 on spontaneous and evoked postoperative pain. Clin Pharmacol Ther 2000; 68:320-7
13. Lashbrook JM, Ossipov MH, Hunter JC, Raffa RB, Tallarida RJ, Porreca F: Synergistic antiallodynic effects of spinal morphine with ketorolac and selective COX1- and COX2-inhibitors in nerve-injured rats. Pain 1999; 82:65-72
14. Gilron I: Is gabapentin a "Broad-spectrum" analgesic? Anesthesiology 2002; 97:537-9
15. Field MJ, Oles RJ, Lewis AS, McCleary S, Hughes J, Singh L. Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents. Br J Pharmacol 1997; 121:1513-22
16. Shimoyama M, Shimoyama N, Inturrisi CE, Elliott KJ: Gabapentin enhances the antinociceptive effects of spinal morphine in the rat tail-flick test. Pain 1997; 72:375-82
17. Matthews EA, Dickenson AH: A combination of gabapentin and morphine mediates enhanced inhibitory effects on dorsal horn neuronal responses in a rat model of neuropathy. ANESTHESIOLOGY 2002; 96:633-40
18. Eckhardt K, Ammon S, Hofmann U, Riebe A, Gugeler N, Mikus G: Gabapentin enhances the analgesic effect of morphine in healthy volunteers. Anesth Analg 2000; 91:185-91
19. Randall LO, Selitto JJ: A method for the measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther 1957; 111:409-419
20. Loomis CW, Milne B, Cervenko FW: Determination of cross tolerance in rat spinal cord using intrathecal infusion via sequential mini-osmotic pumps. Pharmacol Biochem Behav 1987; 26:131-9
21. D'Amour FE, Smith DL: A method for determining loss of pain sensation. J Pharmacol Exp Ther 1941; 72:74-79
22. Owen JA, Milne B, Jhamandas K, Nakatsu K: Assembly of an inexpensive tail flick analgesia meter. J Pharmacol Methods 1981; 6:33-7
23. Powell KJ, Abul-Husn NS, Jhamandas A, Olmstead MC, Beninger RJ, Jhamandas K: Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats. J Pharmacol Exp Ther 2002; 300: 588-96
24. Shimoyama M, Shimoyama N, Hori Y: Gabapentin affects glutamatergic excitatory neurotransmission in the rat dorsal horn. Pain 2000; 85:405-14
25. Chizh BA, Scheede M, Schlutz H: Antinociception and (R,S)-alpha-amino3-hydroxy-5-methyl-4-isoxazole propionic acid antagonism by gabapentin in the rat spinal cord in vivo. Naunyn Schmiedebergs Arch Pharmacol 2000; 362:197-200
26. Maneuf YP, McKnight AT: Block by gabapentin of the facilitation of glutamate release from rat trigeminal nucleus following activation of protein kinase C or adenylyl cyclase. Br J Pharmacol 2001; 134:237-40
27. Gardell LR, Wang R, Burgess SE, Ossipov MH, Vanderah TW, Malan TP Jr, Lai J, Porreca F: Sustained morphine exposure induces a spinal dynorphindependent enhancement of excitatory transmitter release from primary afferent fibers. J Neurosci 2002; 22:6747-55
28. Laughlin TM, Tram KV, Wilcox GL, Birnbaum AK: Comparison of antiepileptic drugs tiagabine, lamotrigine, and gabapentin in mouse models of acute, prolonged, and chronic nociception. J Pharmacol Exp Ther 2002; 302:1168-75
29. Andrews N, Loomis S, Blake R, Ferrigan L, Singh L, McKnight AT: Effect of gabapentin-like compounds on development and maintenance of morphineinduced conditioned place preference. Psychopharmacology 2001; 157:381-7
30. Suman-Chauhan N, Webdale L, Hill DR, Woodruff GN: Characterisation of [3H]gabapentin binding to a novel site in rat brain: homogenate binding studies. Eur J Pharmacol 1993; 244:293-301
31. Gee NS, Brown JP, Dissanayake VU, Offord J, Thurlow R, Woodruff GN: The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J Biol Chem 1996; 271:5768-76
32. Luo ZD, Chaplan SR, Higuera ES, Sorkin LS, Stauderman KA, Williams ME, Yaksh TI.: Upregulation of dorsal root ganglion (alpha)2(delta) calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats. J Neurosci 2001; 21:1868-75